论文部分内容阅读
瑞典Karolinska研究所Lars Oro副教授,应我国对外友协邀请来我国访问,于1978年6月28日在上海作了有关冠心病药物治疗的学术报告。他首先介绍引起冠心病的主要危险因素为高血压、脂蛋白代谢紊乱、糖尿病、抽烟及精神紧张。认为这些危险因素影响冠心病病程的发展和预后。吸烟由于含CO,易引起瘁死。据世界卫生组织调查,冠心病的危险因素达100余种。以后他介绍了β-阻滞剂对冠心患者的保护作用。应用右心导管检查方法研究β-阻滞剂对血液动力学上的影响,发现药物使心搏出量和心肌耗氧量
Lars Oro, an associate professor at Karolinska Institute in Sweden, visited our country at the invitation of China’s Foreign Friendship Association and gave an academic report on the treatment of coronary heart disease in Shanghai on June 28, 1978. He first introduced the main risk factors for coronary heart disease caused by hypertension, lipoprotein metabolism disorders, diabetes, smoking and mental stress. These risk factors that affect the course of coronary heart disease development and prognosis. Smoking due to containing CO, easy to cause death. According to the World Health Organization survey, coronary heart disease risk factors amounted to more than 100 species. Later, he introduced the protective effect of β-blocker on patients with coronary heart disease. The application of right heart catheterization method to study the hemodynamic effects of β-blockers found that drugs to cardiac output and myocardial oxygen consumption